Lamisil

Terbinafine, the active ingredient in Lamisil, is a allylamine antifungal presented as a / for topical use. It treats fungal skin infections such as athlete's foot, ringworm, jock itch and tinea versicolor in adults and children.

GNH USA supplies Lamisil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamisil is an allylamine antifungal used to treat superficial fungal infections of the skin. - Tinea pedis: relieves itching and clears infection of the feet. - Tinea corporis: eliminates ring‑shaped lesions on the body. - Tinea cruris: treats jock itch in the groin area. - Tinea versicolor: reduces discoloured patches caused by yeast. - Dermatophytosis: eradicates a broad range of skin‑affecting dermatophytes.

Lamisil may cause local skin reactions and, rarely, systemic adverse events.

Common Side Effects: - Burning sensation at the application site. - Itching or pruritus. - Redness or erythema. - Dryness or scaling of the skin. - Stinging or tingling feeling. - Mild irritation.

Serious or Rare Side Effects: - Allergic contact dermatitis. - Severe skin reactions such as Stevens‑Johnson syndrome. - Systemic hepatic toxicity (rare with extensive use). - Urticaria or hives. - Photosensitivity reactions. - Anaphylactic shock (extremely rare).

Before using Lamisil, consider the following safety measures. - Assess hypersensitivity: discontinue if allergic reaction occurs. - Avoid use on broken or inflamed skin: may increase systemic absorption. - Do not apply to mucous membranes: product is for external use only. - Limit duration: follow prescribed treatment length to reduce irritation risk. - Seek medical advice for extensive or atypical infections. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Lamisil may interact with other medications or topical agents.

Major Interactions (Avoid): - Concurrent systemic terbinafine (oral): increased systemic exposure. - Potent CYP450 inhibitors (e.g., ketoconazole): may raise terbinafine levels. - Use with other terbinafine‑containing products: risk of overdose.

Moderate Interactions (Monitor Closely): - Co‑application with topical corticosteroids: may mask irritation. - Use with other skin irritants (e.g., retinoids): may enhance local discomfort. - Combination with phototoxic agents: may increase photosensitivity.